The rationale for targeting TGF-beta in chronic liver diseases

Giannelli, G.; Mikulits, W.; Dooley, S.; Fabregat, I.; Moustakas, A.; Dijke, P. ten; ... ; Sanchez, A. (2016)

Article / Letter to editor

• EMT
• galunisertib
• HCC
• targeting TGF-beta RI
• TGF-beta
• tumour progression

• All authors: Giannelli, G.; Mikulits, W.; Dooley, S.; Fabregat, I.; Moustakas, A.; Dijke, P. ten; Portincasa, P.; Winter, P.; Janssen, R.; Leporatti, S.; Herrera, B.; Sanchez, A.
• Date: 2016-04-30
• Journal: European Journal of Clinical Investigation
• Volume: 46
• Issue: 4
• Pages: 349 - 361
• DOI: doi:10.1111/eci.12596